share_log

HC Wainwright & Co. Reiterates Buy on Syros Pharmaceuticals, Maintains $15 Price Target

Moomoo 24/7 ·  Apr 1 07:17

HC Wainwright & Co. analyst Andrew Fein reiterates Syros Pharmaceuticals (NASDAQ:SYRS) with a Buy and maintains $15 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment